NYSE - Delayed Quote USD

Becton, Dickinson and Company (BDX)

236.30 -0.32 (-0.14%)
At close: May 17 at 4:00 PM EDT
236.41 +0.11 (+0.05%)
After hours: May 17 at 6:54 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
19,716,000.00
19,372,000.00
18,870,000.00
19,131,000.00
16,074,000.00
Cost of Revenue
11,584,000.00
11,202,000.00
10,393,000.00
10,500,000.00
9,276,000.00
Gross Profit
8,132,000.00
8,170,000.00
8,477,000.00
8,631,000.00
6,798,000.00
Operating Expense
5,679,000.00
5,746,000.00
6,002,000.00
6,201,000.00
5,587,000.00
Operating Income
2,453,000.00
2,424,000.00
2,475,000.00
2,430,000.00
1,211,000.00
Net Non Operating Interest Income Expense
-375,000.00
-403,000.00
-382,000.00
-460,000.00
-521,000.00
Other Income Expense
-436,000.00
-359,000.00
-308,000.00
-277,000.00
-275,000.00
Pretax Income
1,644,000.00
1,662,000.00
1,783,000.00
1,692,000.00
414,000.00
Tax Provision
265,000.00
132,000.00
148,000.00
88,000.00
62,000.00
Net Income Common Stockholders
1,318,000.00
1,424,000.00
1,689,000.00
2,002,000.00
767,000.00
Diluted NI Available to Com Stockholders
1,318,000.00
1,424,000.00
1,689,000.00
2,002,000.00
767,000.00
Basic EPS
4.54
4.97
5.93
6.92
2.75
Diluted EPS
4.51
4.94
5.88
6.85
2.71
Basic Average Shares
289,209.00
286,282.00
285,005.00
289,288.00
278,971.00
Diluted Average Shares
291,316.50
288,392.00
287,364.00
292,089.00
282,402.00
Total Operating Income as Reported
2,071,000.00
2,111,000.00
2,282,000.00
2,250,000.00
912,000.00
Total Expenses
17,263,000.00
16,948,000.00
16,395,000.00
16,701,000.00
14,863,000.00
Net Income from Continuing & Discontinued Operation
1,333,000.00
1,484,000.00
1,779,000.00
2,092,000.00
874,000.00
Normalized Income
1,732,976.89
1,854,192.00
1,890,843.00
1,900,724.00
627,857.00
Interest Income
93,000.00
49,000.00
16,000.00
9,000.00
7,000.00
Interest Expense
468,000.00
452,000.00
398,000.00
469,000.00
528,000.00
Net Interest Income
-375,000.00
-403,000.00
-382,000.00
-460,000.00
-521,000.00
EBIT
2,112,000.00
2,114,000.00
2,181,000.00
2,161,000.00
942,000.00
EBITDA
4,402,000.00
4,402,000.00
4,410,000.00
4,391,000.00
3,057,000.00
Reconciled Cost of Revenue
11,584,000.00
11,202,000.00
10,393,000.00
10,500,000.00
9,276,000.00
Reconciled Depreciation
2,290,000.00
2,288,000.00
2,229,000.00
2,230,000.00
2,115,000.00
Net Income from Continuing Operation Net Minority Interest
1,379,000.00
1,530,000.00
1,635,000.00
1,604,000.00
352,000.00
Total Unusual Items Excluding Goodwill
-422,000.00
-352,000.00
-279,000.00
-313,000.00
-311,000.00
Total Unusual Items
-422,000.00
-352,000.00
-279,000.00
-313,000.00
-311,000.00
Normalized EBITDA
4,824,000.00
4,754,000.00
4,689,000.00
4,704,000.00
3,368,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-68,023.11
-27,808.00
-23,157.00
-16,276.00
-35,143.00
9/30/2020 - 2/21/1973

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EMBC Embecta Corp.
14.45
+1.76%
 
BAX Baxter International Inc.
35.25
+0.23%
 
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
 
RMD ResMed Inc.
218.57
-0.64%
 
ISRG Intuitive Surgical, Inc.
398.82
+0.60%
 
ALC Alcon Inc.
88.83
-0.26%
 
HOLX Hologic, Inc.
75.02
+0.09%
 
TFX Teleflex Incorporated
217.64
-0.43%
 
COO The Cooper Companies, Inc.
97.31
-0.60%
 
XRAY DENTSPLY SIRONA Inc.
28.28
-0.35%